VYNE Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
VYNE Therapeutics Inc
CIK #0001566044
EDGAR Form CIK 2011 - 2026
10-K [0001566044]
10-Q [0001566044]
3 [0001566044]
4 [0001566044]
8-K [0001566044]
D [0001566044]
SC 13D [0001566044]
SC 13G [0001566044]
Form 13D/13G Filer Form 13D/13G Subject Filed
Zhang Xiaofan VYNE Therapeutics Inc [2026-06-15]
Nantahala Capital Management LLC VYNE Therapeutics Inc [2026-05-15]
AI Biotechnology LLC VYNE Therapeutics Inc [2023-11-13]
Eventide Asset Management LLC VYNE Therapeutics Inc [2023-11-13]
Citadel Advisors LLC VYNE Therapeutics Inc [2023-11-13]
Cormorant Asset Management LP VYNE Therapeutics Inc [2023-11-13]
Soleus Capital Master Fund LP VYNE Therapeutics Inc [2023-11-02]
BlackRock Inc VYNE Therapeutics Inc [2021-02-02]
Perceptive Advisors LLC Menlo Therapeutics Inc [2020-06-11]
Point72 Asset Management LP Menlo Therapeutics Inc [2020-01-21]
View All
Form 3/4/5 Subject 2011 - 2026
Domzalski David
VYNE Therapeutics Inc
Stuart Iain
Zeronda Tyler
Harsch Mutya
Barbari Sharon
Lepore Patrick G
Basta Steven L
Little Elisabeth Sandoval
Bruno Anthony D
Borowski Christine
Access Industries Management LLC
AI Biotechnology LLC
Blavatnik Len
Access Industries Holdings LLC
Perceptive Life Sciences Master Fund Ltd
Edelman Joseph
Perceptive Advisors LLC
Bright Rex
Wiley Matthew T
Saik Andrew
Hirsch Stanley
Hadar Ilan
Ball Kristine M
Krasnow Ronald A
Kwon Paul
McGirr David W J
Whitcup Scott M
Berns Paul L
Royston Aaron
Ebel Ted
Spellman Mary
Watson James F
Sohail Faysal A
Collier David J
CMEA Ventures VII LP
CMEA Ventures VII Parallel LP
Presidio Partners 2007 GP LP
FMR LLC
Cha Albert
venBio Global Strategic Fund II LP
Remeditex Ventures LLC
Vivo Capital Surplus Fund VIII LP
Vivo Capital Fund VIII LP
Vivo Capital VIII LLC
Merck & Co Inc
Merck Sharp & Dohme Corp
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
VYNE Therapeutics Inc VYNE
Common Stock
2025-12-31 Tax withheld 12,684 $0.58 7,357
VYNE Therapeutics Inc VYNE
Common Stock
2025-12-31 Tax withheld 2,448 $0.58 1,420
VYNE Therapeutics Inc VYNE
Common Stock
2025-12-31 Tax withheld 7,858 $0.58 4,558
VYNE Therapeutics Inc VYNE
Common Stock
2025-12-31 Tax withheld 3,579 $0.58 2,076
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
2025-12-12 Grant 20,000 $0.00
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
2025-12-12 Grant 20,000 $0.00
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
2025-12-12 Grant 20,000 $0.00
VYNE Therapeutics Inc VYNE
Stock Option (right to buy) · derivative
2025-12-12 Grant 20,000 $0.00
VYNE Therapeutics Inc VYNE
Common Stock
2025-09-30 Tax withheld 12,676 $0.34 4,310
VYNE Therapeutics Inc VYNE
Common Stock
2025-09-30 Tax withheld 3,581 $0.34 1,218
VYNE Therapeutics Inc VYNE
Common Stock
2025-09-30 Tax withheld 3,420 $0.34 1,163
VYNE Therapeutics Inc VYNE
Common Stock
2025-09-30 Tax withheld 2,453 $0.34 834
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-30 Tax withheld 12,676 $1.65 20,915
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-30 Tax withheld 3,420 $1.65 5,643
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-30 Tax withheld 2,453 $1.65 4,047
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-30 Tax withheld 3,581 $1.65 5,909
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-02 Grant 1,145 $0.81 927
VYNE Therapeutics Inc VYNE
Common Stock
2025-06-02 Grant 8,681 $0.81 7,032
VYNE Therapeutics Inc VYNE
Common Stock
2025-03-31 Tax withheld 8,399 $1.58 13,270
VYNE Therapeutics Inc VYNE
Common Stock
2025-03-31 Tax withheld 6,044 $1.58 9,550
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com